CCXI Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 окт. 2022 @ 23:00):

Stats
Объем за сегодня	656 224
Средний объем	2.02M
Рыночная капитализация	0.00
EPS	$-0.450 ( Q2 \| 2022-08-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-25.93 (Sector) 42.63 (Industry) 24.32
ATR14	$0.378 (0.73%)

AADI -6.49%

ABCL 1.83%

ABCM 0.04%

ABEO -3.55%

ABIO -1.68%

ABOS 4.21%

ABSI 4.76%

ABUS -0.66%

ABVX -1.21%

ACAD 0.00%

ACER -17.95%

ACET -8.50%

ACGN 1.29%

ACHL -2.48%

ACHV 3.88%

ACIU -1.00%

ACLX 0.30%

ACRV -5.61%

ACST -4.89%

ACXP 3.92%

ADAG 6.07%

ADAP -2.70%

ADGI 0.87%

ADIL -1.70%

ADMA -1.73%

ADPT 0.74%

ADTX -2.78%

ADVM 1.30%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.57%

AGEN -3.36%

AGIO -2.01%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.80%

AKRO -2.55%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -1.80%

ALEC 0.00%

ALGS 1.32%

ALKS 1.86%

ALLK -11.44%

ALLO -3.97%

ALLR -2.55%

ALNA 3.16%

ALNY 1.84%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -14.15%

ALVR -0.65%

ALXN 0.00%

ALXO -13.55%

ALZN 4.02%

AMRN -2.51%

AMTI -3.13%

ANAB 1.26%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 1.96%

ANPC -3.15%

APGE 0.80%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.87%

APLT -0.45%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 1.86%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.63%

ARDS -12.13%

ARDX 0.91%

ARGX -0.49%

ARNA 0.00%

ARPO -0.90%

ARQT -2.60%

ARTL -2.50%

ARTLW 0.00%

ARVN 8.16%

ARWR -1.64%

ASLN -3.43%

ASMB -4.22%

ASND -1.86%

ATAI -3.70%

ATHA 6.86%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 4.83%

ATRA -3.60%

ATXI 2.70%

ATXS -0.77%

AUPH -0.90%

AURA 4.55%

AUTL -3.45%

AVBP -3.26%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE 0.35%

AVTX -3.74%

AVXL -5.06%

AXLA 0.00%

AXSM -1.20%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.18%

BCAB -2.95%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.21%

BCRX 1.97%

BCTX 10.31%

BCTXW 13.02%

BCYC 0.95%

BDRX -2.54%

BDTX 0.19%

BEAM 2.56%

BFRA -2.91%

BGNE -2.09%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.47%

BLTE -1.03%

BLU 0.03%

BLUE -2.28%

BMEA -13.53%

BMRN 0.49%

BNOX 6.15%

BNTC -1.69%

BNTX -1.64%

BOLD -7.90%

BOLT -0.05%

BPMC -1.47%

BPTH -1.90%

BPTS -13.47%

BRNS -0.37%

BRTX -5.19%

BTAI 12.81%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 2.08%

CADL 0.80%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -1.08%

CARA -3.29%

CARM 6.96%

CASI 4.08%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.87%

CCXI 0.00%

CDAK 0.00%

CDIO -3.06%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -2.44%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.77%

CDXS 9.66%

CELC -3.15%

CELU 2.67%

CELUW 11.80%

CERC -1.68%

CERE -1.42%

CERO -6.73%

CEROW -10.18%

CFRX -27.95%

CGEM 0.18%

CGEN -3.31%

CGON -1.43%

CGTX -4.35%

CHMA -6.00%

CHRS 4.11%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -0.64%

CLGN 0.00%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.06%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.61%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -36.09%

CNST 0.00%

CNTA 0.11%

CNTB -0.75%

CNTX -4.79%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.57%

COYA 1.14%

CPRX -1.75%

CRBP -0.76%

CRBU -7.10%

CRDF 2.20%

CRGX 0.10%

CRIS -1.59%

CRNX -6.14%

CRSP -0.06%

CRTX 2.63%

CRVO -3.20%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.31%

CUE -1.73%

CVAC -7.34%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.56%

CYTO 0.00%

DARE 3.54%

DAWN -0.90%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 27.23%

DNLI -1.88%

DNTH -4.87%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -3.12%

EDSA 4.09%

EFTR 5.35%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.65%

ELEV -1.24%

ELOX 10.77%

ELTX -5.15%

ELVN -2.14%

ELYM 5.12%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.33%

ENTO -4.97%

ENTX -0.53%

ENVB 8.03%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 0.96%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.88%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 4.76%

EVLO 0.00%

EWTX -1.09%

EXAI -0.19%

EXEL 0.61%

EYEG -0.69%

EYEN 0.59%

EYPT 1.69%

FATE -11.42%

FBIO 0.65%

FBIOP 0.87%

FBLG -7.29%

FBRX -0.02%

FDMT -4.93%

FENC -2.26%

FGEN -9.83%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.37%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.31%

FULC 2.09%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.43%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.65%

GHRS -3.72%

GLMD -4.09%

GLPG -1.56%

GLSI 5.01%

GLTO -3.31%

GLUE -3.43%

GLYC -11.78%

GMAB -0.39%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.42%

GNPX -3.40%

GNTA 3.94%

GOSS -10.88%

GOVX -2.50%

GOVXW 10.89%

GPCR -6.39%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.59%

GRTX -1.66%

GTHX 1.36%

GUTS 2.77%

GXGXW 41.67%

GYRE -4.54%

HALO -1.56%

HARP 0.09%

HCWB -6.13%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX -0.99%

HOOK 1.55%

HOTH -1.10%

HOWL 1.93%

HRMY 5.05%

HRTX 8.86%

HSTO 0.00%

HUMA 1.52%

HUMAW -6.26%

IBRX -5.50%

ICCC -3.10%

ICPT 0.21%

ICU 14.78%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.18%

IFRX -2.78%

IGMS -1.02%

IKNA -0.30%

IKT -9.93%

IMAB 0.58%

IMCR -3.39%

IMGN 0.02%

IMGO 0.00%

IMMP 4.94%

IMMX -6.90%

IMNM 4.46%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.04%

IMTXW 6.00%

IMUX 2.78%

IMV 0.00%

IMVT -3.26%

INAB -0.71%

INBX -2.82%

INCY -2.23%

INDP 7.34%

INFI -52.38%

INKT 2.10%

INM 1.05%

INMB 4.97%

INO 2.48%

INSM -1.00%

INTS -1.96%

INVA 0.28%

INZY 2.29%

IOBT -10.32%

IONS 1.74%

IOVA -2.60%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.54%

ISEE 0.38%

ITOS 1.57%

ITRM 2.33%

IVA 6.96%

IVVD 0.00%

JAGX 1.57%

JANX -4.46%

JAZZ -0.81%

JNCE 0.00%

JSPR -1.60%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -5.47%

KALV -3.55%

KDNY 0.22%

KMPH -0.34%

KNSA -1.85%

KNTE -0.38%

KOD -7.71%

KPRX -4.80%

KPTI -8.59%

KRBP -10.00%

KRON 1.58%

KROS -0.32%

KRRO -2.30%

KRTX 0.03%

KRYS 0.51%

KTRA 11.73%

KTTA -0.65%

KTTAW 0.92%

KURA 0.54%

KYMR -2.87%

KYTX -3.88%

KZIA 4.41%

KZR -0.14%

LABP 0.57%

LBPH -0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.04%

LENZ -1.93%

LEXX -1.54%

LEXXW -14.63%

LGND -1.01%

LGNDV 0.00%

LGVN -10.11%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.78%

LPCN -3.68%

LPTX -2.75%

LQDA 0.33%

LRMR 0.71%

LSTA -1.68%

LTRN 6.48%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -1.77%

LYEL -34.80%

LYRA 1.47%

MACK 0.10%

MBIO -11.36%

MBRX -1.43%

MCRB 3.08%

MDGL -2.32%

MDNA -13.16%

MDWD 3.56%

MDXG -2.14%

MEIP 0.00%

MESO -1.63%

MGNX -4.78%

MGTA -7.74%

MGTX -1.19%

MGX 2.14%

MIRM 0.51%

MIRO 0.59%

MIST 2.69%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX 0.25%

MLYS -6.08%

MNKD -0.57%

MNMD 4.06%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.45%

MORF -3.58%

MREO -1.86%

MRKR -0.43%

MRNA -9.09%

MRNS -5.51%

MRSN -2.86%

MRTX -0.17%

MRUS -0.53%

MRVI -0.11%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.35%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.79%

NKGN 9.91%

NKGNW -18.03%

NKTR 3.27%

NKTX -3.75%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.14%

NMTR -42.97%

NOVN -24.84%

NRBO 16.43%

NRIX -0.53%

NRSN -4.82%

NRSNW 0.00%

NRXP -9.17%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.42%

NTRBW -31.07%

NUVL -0.87%

NVAX -7.57%

NVCT -7.75%

NVIV -34.28%

NXTC -3.53%

NYMX -0.05%

OABI 3.03%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.11%

OCGN 8.05%

OCS -1.00%

OCUL 1.52%

OCUP 0.65%

ODT -4.27%

OKYO 2.15%

OLMA -4.69%

OMER -2.31%

OMGA 0.63%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -2.58%

ORGS -0.69%

ORIC -1.34%

ORMP 18.31%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.67%

OVID 0.01%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.87%

PCSA -1.93%

PCVX 0.04%

PDSB -6.65%

PEPG 1.19%

PGEN -6.30%

PHAR 2.19%

PHAS 0.00%

PHAT -0.48%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.92%

PLUR 7.39%

PMN -5.55%

PMVP -2.68%

PNT 0.16%

PPBT -6.84%

PRAX 7.30%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.45%

PRQR 1.18%

PRTA -2.74%

PRTC 0.62%

PRTG 1.00%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.71%

PTCT -0.61%

PTE -0.82%

PTGX -0.98%

PTIXW -48.41%

PULM 1.57%

PXMD 4.76%

PYPD 1.71%

PYXS 4.59%

QLGN -2.78%

QNCX 5.70%

QNRX 3.40%

QSI -31.62%

QSIAW -3.13%

QTTB 1.83%

QURE -0.78%

RAIN -1.63%

RANI 4.81%

RAPT -1.30%

RARE 1.66%

RCKT -9.85%

REGN -0.30%

RENB -2.80%

REPL -1.26%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.84%

RGNX -6.66%

RIGL -6.24%

RLAY -4.60%

RLMD 0.00%

RLYB -4.35%

RNA 1.93%

RNAC -4.54%

RNAZ -1.92%

RNXT 1.79%

ROIV -1.66%

ROIVW 4.56%

RPHM -1.40%

RPRX -0.58%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.59%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.70%

RYTM -5.99%

RYZB 0.02%

RZLT 3.49%

SABS -1.37%

SABSW -11.81%

SAGE -0.18%

SANA -2.40%

SAVA -1.48%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 10.61%

SCPS 0.00%

SEEL -3.85%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.48%

SGMT -5.08%

SGTX -2.56%

SIOX 22.63%

SLDB -2.93%

SLGL 5.23%

SLN -6.62%

SLNO 0.82%

SLRX 1.21%

SLS -2.56%

SMMT -3.25%

SNDX 3.33%

SNGX -0.38%

SNPX -2.55%

SONN -2.15%

SPPI -0.49%

SPRB -1.38%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.13%

SRRA 0.00%

SRRK -1.49%

SRZN -2.45%

STAB 0.00%

STOK -6.74%

STRO -1.51%

STSA 0.00%

STTK 7.76%

SURF -0.93%

SVRA -0.13%

SWTX 0.22%

SYBX 1.29%

SYRS -1.72%

TALS -0.73%

TARA -6.67%

TARS -2.01%

TBPH 0.71%

TCBP 9.84%

TCDA 0.00%

TCON 1.37%

TCRR 0.00%

TCRT -1.75%

TCRX 5.33%

TECH -0.86%

TENX -0.32%

TERN -8.23%

TFFP -7.61%

TGTX -7.14%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -7.23%

TNGX -3.40%

TNXP -6.40%

TNYA -4.03%

TPST 5.83%

TRDA -4.67%

TRVI 3.07%

TRVN 0.80%

TSHA -19.03%

TSVT -3.99%

TTNP -6.05%

TVTX 3.14%

TYRA -6.67%

UBX -2.13%

UNCY -4.00%

URGN 2.24%

UTHR -0.06%

VACC 11.36%

VALN -6.70%

VAXX 94.50%

VBIV 0.93%

VBLT -8.77%

VCEL 1.04%

VCNX 9.03%

VCYT -0.75%

VERA -5.34%

VERU 2.62%

VERV -2.29%

VIGL -1.88%

VINC 2.93%

VIR -0.71%

VIRI -5.72%

VIRX 3.98%

VKTX -1.67%

VLON -13.04%

VNDA -3.91%

VOR -6.05%

VRCA 0.28%

VRDN -3.68%

VRNA -1.60%

VRPX 1.02%

VRTX 0.07%

VSTM 4.25%

VTGN -1.51%

VTVT 0.39%

VTYX -2.72%

VXRT -1.93%

VYGR -0.64%

VYNE -5.20%

VYNT 7.78%

WINT -0.60%

WVE -8.39%

XBIO 1.03%

XBIT 6.89%

XCUR 3.77%

XENE -1.81%

XERS 5.23%

XFOR 4.71%

XLO 4.42%

XLRN 0.00%

XNCR 0.47%

XOMA -10.03%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.39%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -1.19%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-10-20	Jain Rita	Sell	11 600	Restricted Stock Unit
2022-10-20	Herron Jennifer Lyn	Sell	17 237	Common Stock
2022-10-20	Edwards Thomas A.	Sell	15 723	Restricted Stock Unit
2022-10-20	Parker Geoffrey M.	Sell	15 723	Restricted Stock Unit
2022-10-20	Kanaya Susan M	Sell	90 968	Restricted Stock Unit

INSIDER POWER
-78.69
Last 97 transactions
Buy: 1 451 999 \| Sell: 1 420 462

Объем Корреляция

Длинно: 0.21 (neutral)

Кратко: 0.67 (moderate)

Signal:(79.007) Neutral

ChemoCentryx, Inc. Корреляция

10 Самые положительные корреляции
SANB	0.835

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

ChemoCentryx, Inc. Корреляция - Валюта/Сырье

0.58
( weak )

0.22
( neutral )

0.71
( moderate )

0.47
( neutral )

0.01
( neutral )

-0.87
( strong negative )

ChemoCentryx, Inc. Финансовые показатели

Annual	2021
Выручка:	$32.22M
Валовая прибыль:	$31.92M (99.06 %)
EPS:	$-1.890

FY	2021
Выручка:	$32.22M
Валовая прибыль:	$31.92M (99.06 %)
EPS:	$-1.890

FY	2020
Выручка:	$64.89M
Валовая прибыль:	$64.89M (100.00 %)
EPS:	$-0.840

FY	2019
Выручка:	$35.95M
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$-0.980

Financial Reports:

No articles found.

ChemoCentryx, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ChemoCentryx, Inc.

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.